Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease

Free Radical Biology and Medicine

Volumn 31, Issue 3, 2001, Pages 345-354

  Kontush, Anatol ^a   Mann, Ulrike ^a   Arlt, Sönke ^a   Ujeyl, Amaar ^a   Lührs, Charlotte ^a   Müller Thomsen, Tomas ^a   Beisiegel, Ulrike ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Alzheimer's disease; Antioxidants; Cerebrospinal fluid; Free radicals; Lipoproteins; Oxidation; Plasma; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BRAIN PROTEIN; LIPOPROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; ANTIOXIDANTS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; APOLIPOPROTEINS E; ASCORBIC ACID; CHOLESTEROL; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; TIME FACTORS; TRIGLYCERIDES; VITAMIN E;

EID: 0035425880     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(01)00595-0     Document Type: Article

References (50)

1. Amyloid, the presenilins and Alzheimer's disease
2. Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease
3. Oxidative stress hypothesis in Alzheimer's disease
4. Reactive oxygen species and Alzheimer's disease
5. Vitamin homeostasis in the central nervous system
6. Metals and neuroscience
7. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease
8. Early AGEing and Alzheimer's
9. Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4
10. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease
11. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease
12. Cerebrospinal fluid trace element content in dementia: Clinical, radiologic, and pathologic correlations
13. Iron and aluminum in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients
14. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease
15. Vitamin E and other endogenous antioxidants in the central nervous system
16. Graded dietary levels of RRR-gamma-tocopherol induce a marked increase in the concentrations of alpha- and gamma-tocopherol in nervous tissues, heart, liver and muscle of vitamin-E-deficient rats
17. Effect of dietary vitamin E and selenium on susceptibility of brain regions to lipid peroxidation
18. Lipoprotein oxidation: Mechanistic aspects, methodological approaches and clinical relevance
19. Vitamin E protects nerve cells from amyloid beta protein toxicity
20. Lipoprotein oxidation and Alzheimer's disease
21. Increased lipoprotein oxidation in Alzheimer's disease
22. Lipoproteins and their receptors in the central nervous system
23. Lipoproteins in the brain: A new frontier?
24. Lipoprotein complexes in human cerebrospinal fluid
25. Time-course of oxidation of lipids in human cerebrospinal fluid in vitro
26. Central nervous system lipoproteins in Alzheimer's disease
27. Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo
28. Coantioxidants make alpha-tocopherol an efficient antioxidant for low-density lipoprotein
29. Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: Association with high density lipoproteins
30. Lipoproteins in the central nervous system
31. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
32. Tocopherol-mediated peroxidation. The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein
33. High-performance liquid chromatography-coulometric electrochemical detection of ubiquinol-10, ubiquinone-10, carotenoids, and tocopherols in neonatal plasma
34. How different constituents of human plasma and low density lipoprotein determine plasma oxidizability by copper
35. Azodipyrroles of unconjugated and conjugated bilirubin using diazotized ethyl anthranilate in dimethyl sulfoxide
36. Measurement of antioxidants in human blood plasma
37. Alpha-tocopherol as a reductant for Cu(II) in human lipoproteins
38. Continuous monitoring of in vitro oxidation of human low density lipoprotein
39. Lipid hydroperoxy and hydroxy derivatives in copper-catalyzed oxidation of low density lipoprotein
40. Analysis of lipoprotein diene formation in human serum exposed to copper
41. Measurement of oxidizability of blood plasma
42. A rapid micromethod for apolipoprotein E phenotyping directly in serum
43. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
44. Lipophilic antioxidants in blood plasma as markers of atherosclerosis: The role of α-carotene and γ-tocopherol
45. Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein
46. Oxidized lipoproteins may play a role in neuronal cell death in Alzheimer disease
47. The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity
48. Ascorbate is an outstanding antioxidant in human blood plasma
49. Prevention of tocopherol-mediated peroxidation in ubiquinol-10-free human low density lipoprotein
50. Cosupplementation with coenzyme Q prevents the pro-oxidant effect of alpha-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation